+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy



Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy



Pediatric Infectious Disease Journal 21(5): 388-392



Objective: To investigate epidemiological trends, clinical features and outcome of oesophageal candidosis in the era of highly active antiretroviral therapy in a prospectively monitored population of HIV-infected children and adolescents followed at the National Cancer Institute in Maryland, USA. Patients and methods: The records of all HIV-infected paediatric patients (n=266) followed between 1995 and 2000 were reviewed for a history of oesophageal candidosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003754214

Download citation: RISBibTeXText

PMID: 12150174

DOI: 10.1097/00006454-200205000-00008


Related references

The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection. Journal of Research in Medical Sciences 20(2): 127-132, 2015

The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. Journal of Neurovirology 11(2): 180-189, 2005

Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy. Memorias do Instituto Oswaldo Cruz 102(4): 501-508, 2007

Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy. Enfermedades Infecciosas Y Microbiologia Clinica 19(2): 85-86, 2001

Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy. Lijecnicki Vjesnik 127(5-6): 123-128, 2005

Prevalence of nephrolithiasis in human immunodeficiency virus infected patients on the highly active antiretroviral therapy. Journal of Endourology 26(8): 1095-1098, 2012

Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Journal of Intensive Care Medicine 20(6): 327-333, 2005

Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Archives of Surgery 141(12): 1238-1245, 2006

Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. American Journal of Respiratory and Critical Care Medicine 166(3): 262-267, 2002

Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients. International Journal of Std and Aids 26(11): 796-802, 2015

Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy. Indian Journal of Pathology and Microbiology 53(1): 47-49, 2010

Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 31(6): 1488-1492, 2000

Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. American Journal of Ophthalmology 150(2): 218-222, 2010

Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients. Journal of Infectious Diseases 185(Suppl. 2): S115-S122, 2002

Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatric Infectious Disease Journal 30(1): 45-51, 2011